The pulmonary devices market size has grown rapidly in recent years. It will grow from $1.23 billion in 2023 to $1.36 billion in 2024 at a compound annual growth rate (CAGR) of 10.6%. The increase during the historical period can be linked to a rise in chronic respiratory illnesses, a growing focus on preventive healthcare, higher adoption rates of pulmonology devices, an increase in diseases necessitating endoscopic ultrasound procedures, and a growing elderly population.
The pulmonary devices market size is expected to see rapid growth in the next few years. It will grow to $2.05 billion in 2028 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to an increase in respiratory disease prevalence, escalating levels of air pollution, expansion in-home healthcare services, heightened awareness and early diagnosis initiatives, and the expansion of healthcare infrastructure. Key trends anticipated in the forecast period include the integration of artificial intelligence, the expansion of telemedicine and remote monitoring capabilities, advancements in portable and wearable medical devices, the use of robotic technology in minimally invasive diagnostic procedures, and an increase in home-based care services.
The increase in the prevalence of respiratory diseases is expected to drive growth in the pulmonology devices market. Respiratory diseases encompass a range of medical conditions affecting the airways, lungs, and respiratory muscles, often caused by factors such as air pollution, smoking, and occupational hazards. Pulmonology devices play a crucial role in managing these conditions by facilitating accurate diagnosis, continuous monitoring, and effective treatment through tools such as spirometers, inhalers, pulse oximeters, and ventilators. This ultimately enhances patient outcomes and improves quality of life. For example, according to the Scottish Public Health Observatory, rates of chronic obstructive pulmonary disease (COPD) began to rise as the effects of COVID-19 lessened, underscoring the increasing burden of respiratory diseases. Therefore, the growing prevalence of respiratory diseases is a key driver of the pulmonology devices market.
Leading companies in the pulmonology devices market are focusing on developing innovative products incorporating advanced technologies to enhance patient comfort, treatment efficacy, and the management of various respiratory conditions. One such technology is bilevel positive airway pressure (BiPAP), which provides two pressure settings - one for inhalation (IPAP) and one for exhalation (EPAP) - offering more comfortable continuous pressure for users. For instance, in February 2024, ResMed, a US-based company specializing in cloud-connected medical devices, launched the AirCurve 11 series of advanced BiPAP machines. The AirCurve 11 VAuto model adjusts pressure during exhalation to align more closely with the patient's natural breathing pattern, enhancing comfort and compliance for conditions such as sleep apnea. Additionally, the AirCurve 11 ASV model utilizes adaptive servo-ventilation (ASV) technology, which monitors and adjusts ventilation 50 times per second to stabilize the patient's breathing patterns. These innovations demonstrate a commitment to improving respiratory care through cutting-edge technologies in pulmonology devices.
In March 2022, Sandoz, a subsidiary of Novartis, a Switzerland-based pharmaceutical company, completed the acquisition of Coalesce Product Development Limited for an undisclosed sum. This acquisition is expected to strengthen Sandoz's portfolio in respiratory medicines and enhance patient access to advanced, high-quality therapies. Coalesce Product Development Limited, based in the UK, specializes in medical and drug delivery devices within the respiratory markets, leveraging expertise in mechanical engineering, electronics, and industrial design.
Major companies operating in the pulmonology devices market are Medtronic, Koninklijke Philips N.V., GE Healthcare, Baxter, Boston Scientific Corporation, Medline Industries LP., Olympus Corporation, Omron Healthcare, ResMed, Getinge, ICU Medical Inc., Fisher & Paykel Healthcare Limited, Ambu A/S, Vyaire Medical Inc., Drive DeVilbiss Healthcare, PENTAX Medical, Hamilton Medical, Nonin Medical, CAIRE Inc., Pulmonx Corporation, Verathon Inc., Draegerwerk AG & Co. KGaA, NIOX.
North America was the largest region in the pulmonology devices market in 2023. The regions covered in the pulmonology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pulmonology devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Pulmonology devices encompass medical instruments and equipment employed for diagnosing, treating, and managing respiratory system conditions and diseases. These devices are essential for evaluating lung function, monitoring respiratory health, administering therapeutic interventions, and supporting patients with respiratory disorders.
Key products within the pulmonology devices market include endobronchial ultrasound (EBUS) needles, pulmonary biopsy devices, airway stents, single-use bronchoscopes, and other specialized tools. EBUS needles, utilized during bronchoscopy, are designed for collecting tissue samples from the lungs and nearby lymph nodes. They are used in various conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, tracheal and bronchial stenosis, foreign body extraction, among others. These devices find application in pulmonology clinics, hospitals, and ambulatory surgical centers.
The pulmonology devices market research report is one of a series of new reports that provides pulmonology devices market statistics, including the pulmonology devices industry global market size, regional shares, competitors with pulmonology devices market share, detailed pulmonology devices market segments, market trends, and opportunities, and any further data you may need to thrive in the pulmonology devices industry. These pulmonology devices market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The pulmonary devices market consists of sales of spirometers, peak flow meters, nebulizers, and pulse oximeters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The pulmonary devices market size is expected to see rapid growth in the next few years. It will grow to $2.05 billion in 2028 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to an increase in respiratory disease prevalence, escalating levels of air pollution, expansion in-home healthcare services, heightened awareness and early diagnosis initiatives, and the expansion of healthcare infrastructure. Key trends anticipated in the forecast period include the integration of artificial intelligence, the expansion of telemedicine and remote monitoring capabilities, advancements in portable and wearable medical devices, the use of robotic technology in minimally invasive diagnostic procedures, and an increase in home-based care services.
The increase in the prevalence of respiratory diseases is expected to drive growth in the pulmonology devices market. Respiratory diseases encompass a range of medical conditions affecting the airways, lungs, and respiratory muscles, often caused by factors such as air pollution, smoking, and occupational hazards. Pulmonology devices play a crucial role in managing these conditions by facilitating accurate diagnosis, continuous monitoring, and effective treatment through tools such as spirometers, inhalers, pulse oximeters, and ventilators. This ultimately enhances patient outcomes and improves quality of life. For example, according to the Scottish Public Health Observatory, rates of chronic obstructive pulmonary disease (COPD) began to rise as the effects of COVID-19 lessened, underscoring the increasing burden of respiratory diseases. Therefore, the growing prevalence of respiratory diseases is a key driver of the pulmonology devices market.
Leading companies in the pulmonology devices market are focusing on developing innovative products incorporating advanced technologies to enhance patient comfort, treatment efficacy, and the management of various respiratory conditions. One such technology is bilevel positive airway pressure (BiPAP), which provides two pressure settings - one for inhalation (IPAP) and one for exhalation (EPAP) - offering more comfortable continuous pressure for users. For instance, in February 2024, ResMed, a US-based company specializing in cloud-connected medical devices, launched the AirCurve 11 series of advanced BiPAP machines. The AirCurve 11 VAuto model adjusts pressure during exhalation to align more closely with the patient's natural breathing pattern, enhancing comfort and compliance for conditions such as sleep apnea. Additionally, the AirCurve 11 ASV model utilizes adaptive servo-ventilation (ASV) technology, which monitors and adjusts ventilation 50 times per second to stabilize the patient's breathing patterns. These innovations demonstrate a commitment to improving respiratory care through cutting-edge technologies in pulmonology devices.
In March 2022, Sandoz, a subsidiary of Novartis, a Switzerland-based pharmaceutical company, completed the acquisition of Coalesce Product Development Limited for an undisclosed sum. This acquisition is expected to strengthen Sandoz's portfolio in respiratory medicines and enhance patient access to advanced, high-quality therapies. Coalesce Product Development Limited, based in the UK, specializes in medical and drug delivery devices within the respiratory markets, leveraging expertise in mechanical engineering, electronics, and industrial design.
Major companies operating in the pulmonology devices market are Medtronic, Koninklijke Philips N.V., GE Healthcare, Baxter, Boston Scientific Corporation, Medline Industries LP., Olympus Corporation, Omron Healthcare, ResMed, Getinge, ICU Medical Inc., Fisher & Paykel Healthcare Limited, Ambu A/S, Vyaire Medical Inc., Drive DeVilbiss Healthcare, PENTAX Medical, Hamilton Medical, Nonin Medical, CAIRE Inc., Pulmonx Corporation, Verathon Inc., Draegerwerk AG & Co. KGaA, NIOX.
North America was the largest region in the pulmonology devices market in 2023. The regions covered in the pulmonology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pulmonology devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Pulmonology devices encompass medical instruments and equipment employed for diagnosing, treating, and managing respiratory system conditions and diseases. These devices are essential for evaluating lung function, monitoring respiratory health, administering therapeutic interventions, and supporting patients with respiratory disorders.
Key products within the pulmonology devices market include endobronchial ultrasound (EBUS) needles, pulmonary biopsy devices, airway stents, single-use bronchoscopes, and other specialized tools. EBUS needles, utilized during bronchoscopy, are designed for collecting tissue samples from the lungs and nearby lymph nodes. They are used in various conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, tracheal and bronchial stenosis, foreign body extraction, among others. These devices find application in pulmonology clinics, hospitals, and ambulatory surgical centers.
The pulmonology devices market research report is one of a series of new reports that provides pulmonology devices market statistics, including the pulmonology devices industry global market size, regional shares, competitors with pulmonology devices market share, detailed pulmonology devices market segments, market trends, and opportunities, and any further data you may need to thrive in the pulmonology devices industry. These pulmonology devices market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The pulmonary devices market consists of sales of spirometers, peak flow meters, nebulizers, and pulse oximeters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Pulmonology Devices Market Characteristics3. Pulmonology Devices Market Trends and Strategies32. Global Pulmonology Devices Market Competitive Benchmarking33. Global Pulmonology Devices Market Competitive Dashboard34. Key Mergers and Acquisitions in the Pulmonology Devices Market
4. Pulmonology Devices Market - Macro Economic Scenario
5. Global Pulmonology Devices Market Size and Growth
6. Pulmonology Devices Market Segmentation
7. Pulmonology Devices Market Regional and Country Analysis
8. Asia-Pacific Pulmonology Devices Market
9. China Pulmonology Devices Market
10. India Pulmonology Devices Market
11. Japan Pulmonology Devices Market
12. Australia Pulmonology Devices Market
13. Indonesia Pulmonology Devices Market
14. South Korea Pulmonology Devices Market
15. Western Europe Pulmonology Devices Market
16. UK Pulmonology Devices Market
17. Germany Pulmonology Devices Market
18. France Pulmonology Devices Market
19. Italy Pulmonology Devices Market
20. Spain Pulmonology Devices Market
21. Eastern Europe Pulmonology Devices Market
22. Russia Pulmonology Devices Market
23. North America Pulmonology Devices Market
24. USA Pulmonology Devices Market
25. Canada Pulmonology Devices Market
26. South America Pulmonology Devices Market
27. Brazil Pulmonology Devices Market
28. Middle East Pulmonology Devices Market
29. Africa Pulmonology Devices Market
30. Pulmonology Devices Market Competitive Landscape and Company Profiles
31. Pulmonology Devices Market Other Major and Innovative Companies
35. Pulmonology Devices Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Pulmonology Devices Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on pulmonology devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pulmonology devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pulmonology devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product Type: Endobronchial Ultrasound (EBUS) Needles; Pulmonary Biopsy Devices; Airway Stents; Single-Use Bronchoscopes; Other Product Types2) By Indication: Chronic Obstructive Pulmonary Disease (COPD); Lung Cancer; Tracheal And Bronchial Stenosis; Foreign Body Extraction; Other Indications
3) By End-User: Pulmonology Clinics; Hospitals; Ambulatory Surgical Centers
Key Companies Mentioned: Medtronic; Koninklijke Philips N.V.; GE Healthcare; Baxter; Boston Scientific Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic
- Koninklijke Philips N.V.
- GE Healthcare
- Baxter
- Boston Scientific Corporation
- Medline Industries LP.
- Olympus Corporation
- Omron Healthcare
- ResMed
- Getinge
- ICU Medical Inc.
- Fisher & Paykel Healthcare Limited
- Ambu A/S
- Vyaire Medical Inc.
- Drive DeVilbiss Healthcare
- PENTAX Medical
- Hamilton Medical
- Nonin Medical
- CAIRE Inc.
- Pulmonx Corporation
- Verathon Inc.
- Draegerwerk AG & Co. KGaA
- NIOX
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 175 |
Published | August 2024 |
Forecast Period | 2024 - 2028 |
Estimated Market Value ( USD | $ 1.36 Billion |
Forecasted Market Value ( USD | $ 2.05 Billion |
Compound Annual Growth Rate | 10.8% |
Regions Covered | Global |